Myofibroblasts: function, formation, and scope of molecular therapies for skin fibrosis

Y Tai, EL Woods, J Dally, D Kong, R Steadman… - Biomolecules, 2021 - mdpi.com
Myofibroblasts are contractile, α-smooth muscle actin-positive cells with multiple roles in
pathophysiological processes. Myofibroblasts mediate wound contractions, but their …

Chitosan nanoparticles and based composites as a biocompatible vehicle for drug delivery: a review

R Pathak, S Bhatt, VD Punetha, M Punetha - International Journal of …, 2023 - Elsevier
The shellfish processing industry is one of the largest growing industries across the globe
with a market size of around USD 62B. However, it also leads to a significant environmental …

Renal endothelial cell‐targeted extracellular vesicles protect the kidney from ischemic injury

K Zhang, R Li, X Chen, H Yan, H Li, X Zhao… - Advanced …, 2023 - Wiley Online Library
Endothelial cell injury plays a critical part in ischemic acute kidney injury (AKI) and
participates in the progression of AKI. Targeting renal endothelial cell therapy may …

[HTML][HTML] Targeted therapy of kidney disease with nanoparticle drug delivery materials

S Shang, X Li, H Wang, Y Zhou, K Pang, P Li, X Liu… - Bioactive Materials, 2024 - Elsevier
With the development of nanomedicine, nanomaterials have been widely used, offering
specific drug delivery to target sites, minimal side effects, and significant therapeutic effects …

Functional Au nanoparticles for engineering and long-term CT imaging tracking of mesenchymal stem cells in idiopathic pulmonary fibrosis treatment

H Bao, S Cheng, X Li, Y Li, C Yu, J Huang, Z Zhang - Biomaterials, 2022 - Elsevier
Idiopathic pulmonary fibrosis (IPF) therapy has always been a big and long-standing
challenge in clinical practice due to the lack of miraculous medicine. Mesenchymal stem …

Circulating non-coding RNAs in chronic kidney disease and its complications

AJ van Zonneveld, Q Zhao, JI Rotmans… - Nature Reviews …, 2023 - nature.com
Post-transcriptional regulation by non-coding RNAs (ncRNAs) can modulate the expression
of genes involved in kidney physiology and disease. A large variety of ncRNA species exist …

The application of nanoparticles in diagnosis and treatment of kidney diseases

P Paluszkiewicz, A Martuszewski, N Zaręba… - International Journal of …, 2021 - mdpi.com
Nanomedicine is currently showing great promise for new methods of diagnosing and
treating many diseases, particularly in kidney disease and transplantation. The unique …

Hyaluronic‐Acid‐Coated Chitosan Nanoparticles for Insulin Oral Delivery: Fabrication, Characterization, and Hypoglycemic Ability

H Wu, T Guo, J Nan, L Yang, G Liao… - Macromolecular …, 2022 - Wiley Online Library
Oral administration of insulin faces multiple biological challenges, such as varied digestive
environments, mucin exclusion, and low epithelial cells' absorption. In the present study, a …

A quantitative review of nanotechnology‐based therapeutics for kidney diseases

HT Cheng, YN Ngoc Ta, T Hsia… - Wiley Interdisciplinary …, 2024 - Wiley Online Library
Kidney‐specific nanocarriers offer a targeted approach to enhance therapeutic efficacy and
reduce off‐target effects in renal treatments. The nanocarriers can achieve organ or cell …

Concentrated small extracellular vesicles from menstrual blood-derived stromal cells improve intrauterine adhesion, a pre-clinical study in a rat model

S Zhang, Q Chang, P Li, X Tong, Y Feng, X Hao… - Nanoscale, 2021 - pubs.rsc.org
We previously reported that transplantation of menstrual blood-derived stromal cells
(MenSCs) significantly improved fertility restoration in intrauterine adhesion (IUA). However …